PRC
ELGX

Platte River Capital’s Endologix Inc ELGX Stock Holding History

Platte River Capital’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8,600
Closed -$1.11M – 233
2014
Q1 		$1.11M Buy
+8,600
New +$1.34M 0.15% 138

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Platte River Capital's ELGX Position: Q2 2014 in Review

Platte River Capital sold out of Endologix Inc (ELGX) in Q2 2014, closing a stake of 8,600 shares — an estimated $1.11M sold.

Platte River Capital first reported a position in ELGX in Q1 2014 and held it in 1 quarter. The position peaked at $1.11M in Q1 2014. 119 funds tracked by Wall St. Rank hold ELGX as of Q2 2014.

  • Platte River Capital reported no remaining Endologix Inc position as of Q2 2014 after selling out during the quarter.
  • Platte River Capital sold 8,600 Endologix Inc shares in Q2 2014, an estimated $1.11M.
  • Platte River Capital first reported a position in Endologix Inc in Q1 2014 and held it in 1 quarter.
  • Platte River Capital's Endologix Inc position peaked at $1.11M in Q1 2014.
  • 119 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2014.

Based on Platte River Capital's 13F filing for Q2 2014, filed 29 Jul 2014.